HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Hepatocellular Carcinoma (HCC) is a primary malignancy that originates in the liver cells, specifically hepatocytes. It is the most common form of liver cancer and often develops in individuals with underlying liver diseases, such as cirrhosis or chronic hepatitis B and C infections. This type of cancer typically progresses silently in its early stages, often without noticeable symptoms. As a result, diagnosis is frequently made at advanced stages when treatment options may be limited. Common symptoms that may manifest as the disease progresses include abdominal pain, unexplained weight loss, and jaundice. The risk factors for HCC are diverse, with chronic viral hepatitis, excessive alcohol consumption, and certain metabolic disorders being prominent contributors. Additionally, aflatoxin exposure, a toxin produced by certain molds that can contaminate food, is recognized as a risk factor in some regions. Diagnostic tools for HCC include imaging studies such as ultrasound, CT scans, and MRI, as well as blood tests to assess liver function and tumor markers. Treatment options vary depending on the stage of the cancer and the overall health of the patient. Surgical resection, liver transplantation, radiofrequency ablation, and transarterial chemoembolization are among the therapeutic interventions employed. Prevention strategies are crucial in managing HCC, emphasizing vaccination against hepatitis B, timely treatment of viral hepatitis infections, and lifestyle modifications to reduce the risk of cirrhosis. Regular surveillance of individuals at high risk, such as those with chronic liver disease, is essential for early detection and intervention. Despite advancements in treatment modalities, the prognosis for HCC remains guarded, particularly in advanced cases. Ongoing research aims to improve understanding of the molecular mechanisms underlying hepatocellular carcinoma, paving the way for novel therapeutic approaches and early detection strategies to enhance patient outcomes.
